Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED)

v3.22.2.2
CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Product sales, net $ 3,751 $ 5,107 $ 12,336 $ 15,079
Cost of goods sold 2,189 2,749 8,348 8,073
Gross profit 1,562 2,358 3,988 7,006
Operating expenses:        
Research and development 44 410 267 821
Selling, general and administrative 2,410 4,928 8,443 15,788
 Total operating expenses 2,454 5,338 8,710 16,609
Operating loss (892) (2,980) (4,722) (9,603)
Gain on debt extinguishment (127) (2,945) (127) (2,945)
Interest expense 266 5 1,304 28
Loss before income taxes (1,031) (40) (5,899) (6,686)
Income tax expense 0 0 2 11
Net loss (1,031) (40) (5,901) (6,697)
Deemed dividend for beneficial conversion of Series A convertible preferred stock 0 0 920 0
Net loss attributable to common stockholders (1,031) (40) (6,821) (6,697)
Net loss attributable to common stockholders $ (1,031) $ (40) $ (6,821) $ (6,697)
Weighted average common shares outstanding, basic (in shares) 146,530 109,115 133,651 107,099
Weighted average common shares outstanding, diluted (in shares) 146,530 109,115 133,651 107,099
Net loss per share attributable to common stockholders, basic (in USD per share) $ (0.01) $ (0.00) $ (0.05) $ (0.06)
Net loss per share attributable to common stockholders, diluted (in USD per share) $ (0.01) $ (0.00) $ (0.05) $ (0.06)
Revenue, product and service [Extensible List] Product [Member] Product [Member] Product [Member] Product [Member]